发明名称 Use of proteases for gluten intolerance
摘要 The present technology relates to an enzyme composition. The enzyme composition may be used to treat gluten intolerant subjects, including suffering from non-Celiac gluten intolerance and/or non-Celiac gluten sensitivity. The enzyme composition may also be used to reduce gluten exposure in certain individuals. For example, the enzyme composition may also be used as a prophylactic to reduce exposure to gluten oligopeptides.
申请公布号 US9498520(B2) 申请公布日期 2016.11.22
申请号 US201514593203 申请日期 2015.01.09
申请人 AMANO ENZYME INC.;AMANO ENZYME USA CO. LTD. 发明人 Jolly James F.;Ido Horoki;Matsubara Hirotaka;Takahashi Tetsuya;Nishio Kyoichi
分类号 A61K38/48;A61K38/17;A61K38/22;A61K38/24;A61K38/43 主分类号 A61K38/48
代理机构 McAndrews, Held & Malloy, Ltd. 代理人 McAndrews, Held & Malloy, Ltd.
主权项 1. A method of treating gluten intolerance or reducing gluten exposure in a human subject comprising: orally administering the subject with a therapeutically effective amount of an enzyme cocktail comprising a gluten degrading enzyme preparation isolated from Aspergillus oryzae with specificity for peptide substrate leucyl-glycyl-glycine (GDEP-LGG), papain, a semi-alkali protease and an enzyme preparation from Penicillium citrinum, wherein the enzyme cocktail degrades a gluten oligopeptide of SEQ ID NO:1 into peptide fragments of four amino acids or less at acidic conditions, and wherein the GDEP-LGG and papain are in a percent relative activity ratio of 80:20 to 20:80.
地址 Nagoya JP